ARMISTICE CAPITAL, LLC

Q2 2023 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2023
Date filed
8/14/2023
Form type
13F-HR
Num holdings
221
Total value ($000)
$6,911,419
Net value change ($000)
-33,458 (-0.5%)
New positions
67
Sold out positions
74
Turnover %
25.9%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2023 Next filing: 11/14/2023 SEC filing

Snapshot: Change Analysis

Compared to Q1 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
PFE 76,881 NEW
NEVRO CORP 59,890 NEW
JAZZ 56,530 NEW
REGN 46,372 108.5%
KDP 42,121 NEW
CPB 35,654 NEW
PG 31,324 5790.0%
BMY 25,580 NEW
TERRAN ORBITAL CORPORATION 22,988 NEW
S 22,881 260.9%
Top Reduces (Value $000, Stocks/ETFs)
GSK -104,445 -90.7%
OGN -75,264 -100.0%
CENT -53,291 -100.0%
BIIB -52,192 -41.7%
EXAS -47,629 -51.8%
TVTX -46,327 -28.8%
IVERIC bio, Inc. -44,670 -100.0%
DICE Therapeutics, Inc. -39,422 -100.0%
ENTA -37,795 -46.5%
MDGL -35,448 -53.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 2,928,227 (42.4% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type